AstraZeneca and Sandoz resolve Faslodex patent litigation

13-07-2016

AstraZeneca announced today that it has entered into an agreement with Sandoz to resolve patent litigation between the two companies.


AstraZeneca, Sandoz, agreement, patent, Faslodex, fulvestrant

LSIPR